UniSa - IRIS Institutional Research Information System

AGLITTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.204
NA - Nord America 937
EU - Europa 441
SA - Sud America 109
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 25
OC - Oceania 2
Totale 3.777
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 1.699
US - Stati Uniti d'America 907
SG - Singapore 209
IT - Italia 157
CN - Cina 109
RU - Federazione Russa 82
BR - Brasile 77
VN - Vietnam 49
DE - Germania 43
GB - Regno Unito 29
DK - Danimarca 25
TR - Turchia 23
BD - Bangladesh 22
FR - Francia 22
IE - Irlanda 22
IN - India 19
KR - Corea 15
JP - Giappone 12
AR - Argentina 11
MX - Messico 11
UA - Ucraina 11
CA - Canada 10
FI - Finlandia 9
SE - Svezia 9
ZA - Sudafrica 9
IQ - Iraq 8
PK - Pakistan 7
ES - Italia 6
NL - Olanda 6
PL - Polonia 6
SA - Arabia Saudita 6
VE - Venezuela 6
EC - Ecuador 5
PH - Filippine 5
AT - Austria 4
CO - Colombia 4
KE - Kenya 4
RO - Romania 4
EG - Egitto 3
LT - Lituania 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
ID - Indonesia 2
JO - Giordania 2
OM - Oman 2
SN - Senegal 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BS - Bahamas 1
GA - Gabon 1
LB - Libano 1
LC - Santa Lucia 1
MA - Marocco 1
MG - Madagascar 1
ML - Mali 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
TG - Togo 1
UZ - Uzbekistan 1
Totale 3.720
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.696
Singapore 130
San Jose 106
Chandler 94
Ashburn 88
Princeton 70
Ann Arbor 69
Milan 54
Dallas 32
Woodbridge 31
Beijing 29
Jacksonville 26
Los Angeles 26
Council Bluffs 23
Moscow 23
Dublin 22
The Dalles 22
Izmir 17
Ho Chi Minh City 16
Lauterbourg 16
Andover 15
Washington 15
New York 13
Nürnberg 13
São Paulo 13
Rome 12
Wilmington 12
Copenhagen 11
Naples 11
Tokyo 11
Munich 10
Brooklyn 8
Chennai 8
Houston 8
Johannesburg 8
Nanjing 8
Santa Clara 8
Chicago 7
Hanoi 7
Salerno 7
Turku 7
Fairfield 6
Baghdad 5
Columbus 5
Denver 5
Guangzhou 5
London 5
Norwalk 5
Redwood City 5
San Giorgio A Cremano 5
Amsterdam 4
Ankara 4
Atlanta 4
Caracas 4
Frederiksberg 4
Hebei 4
Jinan 4
Mexico City 4
Nairobi 4
Nanchang 4
Phoenix 4
Pontecagnano 4
Poplar 4
Saint Petersburg 4
Shanghai 4
Toronto 4
Warsaw 4
Bolzano 3
Cairo 3
Caxias do Sul 3
Contagem 3
Falls Church 3
Figino 3
Haiphong 3
Latina 3
Memphis 3
Nuremberg 3
Quận Bình Thạnh 3
Turin 3
Addis Ababa 2
Bandar Seri Begawan 2
Boardman 2
Brasília 2
Can Tho 2
Changsha 2
Charlotte 2
Cincinnati 2
Dakar 2
Faisalabad 2
Frankfurt am Main 2
Guatemala City 2
Guayaquil 2
Haikou 2
Jackson 2
Jeddah 2
Justo Daract 2
Kuala Lumpur 2
La Paz 2
Medellín 2
Mercato San Severino 2
Totale 2.994
Salva come PNG Salva come JPEG
Nome #
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 767
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 399
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 380
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 322
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 211
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 192
The diagnostic conundrum in non-alcoholic fatty liver disease 190
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 153
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 150
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 128
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 123
Viral hepatitis: Milestones, unresolved issues, and future goals 113
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 111
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease 97
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 94
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome 91
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 87
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy 87
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 82
Totale 3.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.743
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022125 0 2 5 0 6 2 4 5 21 11 16 53
2022/2023190 19 14 23 17 16 48 0 16 18 2 12 5
2023/2024146 7 8 17 9 20 40 0 9 6 5 8 17
2024/2025349 2 8 4 10 20 47 73 23 33 30 48 51
2025/20262.557 281 937 568 46 173 69 132 33 89 109 16 104
2026/202729 25 4 0 0 0 0 0 0 0 0 0 0
Totale 3.777